Biomatter.ai: Revolutionizing Enzyme Design with AI-Powered Precision

Biomatter.ai is a cutting-edge AI platform developed by Biomatter Inc. that leverages Intelligent Architecture™ to enable precise, digital design of proteins and enzymes. By combining artificial intelligence with physics-driven modeling, it empowers researchers and innovators to create novel enzyme-based solutions with unprecedented control and efficiency, accelerating development timelines and reducing experimental trial and error. The platform has successfully designed a wide range of complex enzymes, from glycosyltransferases to proteolytic enzymes, and is already driving breakthroughs in health and sustainable manufacturing through high-impact collaborations with industry leaders like Neogen® Corporation and Kirin. Its advanced LYNX Enzyme Optimization™ tool further enhances enzyme performance, making it a powerful ally in biotech innovation.

Key Features:

• Intelligent Architecture™ Platform: AI-driven digital design of proteins and enzymes with near-perfect precision.
• AI & Physics-Driven Redesign: LYNX Enzyme Optimization™ enables advanced enzyme redesign for enhanced functionality.
• Accelerated Development Timelines: Reduces experimental burden and shortens protein engineering cycles.
• End-to-End Solution Development: Supports projects from concept through scale-up and protein production.
• Flexible Partnership Models: Offers customizable collaboration and risk-sharing arrangements for clients.
• Diverse Enzyme Design Capabilities: Proven success in designing glycosyltransferases, RNA polymerases, endonucleases, dehydrogenases, ketoreductases, and more.
• Sustainable & Health-Focused Innovation: Mission-driven development of enzymes for health applications and eco-friendly manufacturing.

Pricing: Biomatter.ai operates under a flexible partnership model, offering tailored solutions with risk-sharing schemes—ideal for advanced research and commercial applications.

Conclusion: Biomatter.ai stands at the forefront of bioengineering innovation, delivering transformative enzyme design capabilities through AI and physics, empowering scientists and industry leaders to pioneer sustainable and health-focused breakthroughs faster than ever before.